Avistone Biotechnology Co., Ltd.

This study is testing a new targeted drug called andamertinib, given alone or with standard chemotherapy, for adults with advanced non-small cell lung cancer. It is for people whose cancer has specific, less common genetic changes (atypical EGFR mutations) and who have not yet re…

This is the first study in people testing a new drug called ANS03 for advanced solid tumors that have specific genetic changes (ROS1 or NTRK). The main goals are to find a safe dose, see how the body processes the drug, and look for early signs that it might help shrink tumors. T…

This is the first human study of an experimental drug called ANS014004 for people with advanced solid tumors that have spread or cannot be removed by surgery. The main goal is to check the drug's safety, side effects, and how the body processes it in about 63 adult participants. …